Anti-Obesity Pharmacotherapy

This track showcases advancements in weight-loss medications, including appetite suppressants, metabolic enhancers, and GLP-1–based therapies. Researchers will present clinical trial data, safety profiles, and dosing strategies. The session explores the integration of pharmacotherapy with lifestyle modifications for enhanced outcomes. Discussions include long-term efficacy, patient adherence, and emerging drug pipelines. Regulatory considerations and global approvals will be reviewed. Clinicians will benefit from updated therapeutic guidelines.

 

    Related Conference of Anti-Obesity Pharmacotherapy

    January 26-27, 2026

    20th International Conference on Obesity Medicine

    Rome, Italy
    March 26-27, 2026

    28th Global Obesity Meeting

    London, UK
    June 15-16, 2026

    22nd Euro Obesity and Endocrinology Congress

    Amsterdam, Netherlands
    July 23-24, 2026

    26th Global Summit on Obesity

    London, UK

    Anti-Obesity Pharmacotherapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in